Bronchiolitis obliterans syndrome and survival following lung transplantation for patients with sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 25, Issue 2, 2008, Pages 117-124

  Wille, Keith M ^a,b   Gaggar, A ^a   Hajari, A S ^a   Leon, K J ^a   Barney, J B ^a   Smith, K H ^b   Pajaro, O ^c   Wang, W ^a   Oster, R A ^a   McGiffin, D C ^c   Young, K R ^c  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Kentucky   (United States)

Author keywords

BOS; Bronchiolitis obliterans syndrome; Idiopathic pulmonary fibrosis; IPF; Lung transplantation; Sarcoidosis

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; SARCOIDOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; BRONCHIOLITIS OBLITERANS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; SURVIVAL RATE; UNITED STATES;

EID: 62549116549     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999; 14: 735-7.
2. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/ World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
3. Shorr AF, Davies DB, Nathan SD. Outcomes for patients with sarcoidosis awaiting lung transplantation. Chest 2002; 122: 233-8.
4. Shorr AF, Helman DL, Davies DB, et al. Sarcoidosis, race, and short-term outcomes following lung transplantation. Chest 2004; 125: 990-6.
5. Walker S, Mikhail G, Banner N, et al. Medium term results of lung transplantation for end stage pulmonary sarcoidosis. Thorax 1998; 53: 281-4.
6. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15: 1-15.
7. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
8. Kirklin JK, Brown RN, Huang ST, et al. Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis. J Heart Lung Transplant 2006; 25: 283-8.
9. Muller C, Briegel J, Haller M, et al. Sarcoidosis recurrence following lung transplantation. Transplantation 1996; 61: 1117-9.
10. Nunley DR, Hattler B, Keenan RJ, et al. Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 93-100.
11. Judson MA. Lung transplantation for pulmonary sarcoidosis. Eur Respir J 1998; 11: 738-44.
12. Neuringer IP, Chalermskulrat W, Aris R. Obliterative bronchiolitis or chronic lung allograft rejection: a basic science review. J Heart Lung Transplant 2005; 24: 3-19.
13. Milman N, Burton C, Andersen CB, et al. Lung transplantation for end-stage pulmonary sarcoidosis: outcome in a series of seven consecutive patients. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 222-8.
14. Arcasoy SM, Christie JD, Pochettino A, et al. Characteristics and Outcomes of Patients With Sarcoidosis Listed for Lung Transplantation. Chest 2001; 120: 873-80.
15. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336: 1224-34.